From the Issue
Cardio-Oncology: Matters of the Heart in Hematologic Cancers
Cardio-oncology is a collaborative effort between cardiology and oncology to address relationships between cancer, cancer treatments, and heart health.
Immune Checkpoint Combinations in Classical Hodgkin Lymphoma
The use of antibodies that block PD-1/PD-1 ligand signaling have resulted in high response rates in clinical trials and have led to the approval of nivolumab and pembrolizumab in patients with relapsed and refractory classical Hodgkin lymphoma.
Rare Blood Cancers in 2018 & Beyond
A surprisingly With the increased understanding of underlying disease state mechanisms and our immune system, new targeted chemo and immunotherapy approaches have been developed for the treatment of many forms of cancer.
Read More Research Highlights
Are you looking for the latest hematology/oncology research? Check out additional highlights featuring the cutting-edge discoveries in the field.
Looking for resources to share with your colleagues and patients? Check out patient handouts on a variety of topics, including “Maximizing Resilience,” which encourages patients to think about resilience in new ways and take steps to building this quality.